Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Scotiabank Maintains Sector Outperform on Oracle, Raises Price Target to $360

Scotiabank analyst Patrick Colville maintains Oracle (NYSE:ORCL) with a Sector Outperform and raises the price target from $350 to $360.

byBenzinga Newsdesk

October 17, 2025

1 minute read

Scotiabank analyst Patrick Colville maintains Oracle (NYSE:ORCL) with a Sector Outperform and raises the price target from $350 to $360.

Mizuho Initiates Coverage On IN8bio with Buy Rating, Announces Price Target of $12

By Benzinga Newsdesk

Today, 4:38 PM

Mizuho analyst Mara Goldstein initiates coverage on IN8bio (NASDAQ:INAB) with a Buy rating and announces Price Target of $12.

INAB

Silverback Therapeutics Q2 EPS $(0.70) Up From $(9.65) YoY

By Benzinga Newsdesk

Today, 4:38 PM

Silverback Therapeutics (NASDAQ:SBTX) reported quarterly losses of $(0.70) per share. This is a 92.75 percent increase over losses of $(9.65) per share from the same period last year.

SBTX

Vitalik Buterin’s Optimistic Outlook Leads To This Crypto Outperforming Bitcoin, Ethereum Gains

By Mehab Qureshi

Today, 4:38 PM

Solana (CRYPTO: SOL) has seen its value increase by 12% over the last 24 hours, pushing it beyond the $11 mark.

BTC

What Does Rite Aid’s Debt Look Like?

By Benzinga Insights

Today, 4:38 PM

Shares of Rite Aid (NYSE:RAD) moved lower by 16.98% in the past three months. Before we understand the importance of debt, let us look at how much debt Rite Aid has.

RAD

Scotiabank Maintains Sector Outperform on Oracle, Raises Price Target to $360

Related Posts

Mizuho Initiates Coverage On IN8bio with Buy Rating, Announces Price Target of $12

Silverback Therapeutics Q2 EPS $(0.70) Up From $(9.65) YoY

Vitalik Buterin’s Optimistic Outlook Leads To This Crypto Outperforming Bitcoin, Ethereum Gains

What Does Rite Aid’s Debt Look Like?